“◐체온을 느끼자◑ωωω. YEOTOP6.COM 솔샘오피Ⅷ솔샘립카페⌒솔샘오피✕솔샘안마ⅹ솔샘스파は솔샘OP✄솔샘마사지”的搜索结果，显示 271-280 项，共有 12248 项

  1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of participants (10 ...

  2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... X-ray therapy, but this study will administer treatment in approximately 3 weeks. To achieve this shorter course, proton therapy is used. This study aims to ...

  3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... X-ray therapy, but this study will administer treatment in approximately 3 weeks. To achieve this shorter course, proton therapy is used. This study aims to ...

  4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... X-ray therapy, but this study will administer treatment in approximately 3 weeks. To achieve this shorter course, proton therapy is used. This study aims to ...

  5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... X-ray therapy, but this study will administer treatment in approximately 3 weeks. To achieve this shorter course, proton therapy is used. This study aims to ...

  6. 小儿神经外科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in ...

  7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This study aims to demonstrate acceptability and feasibility of the use of Distance Reiki therapy versus sham Reiki therapy among multiple myeloma patients.

  8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

  9. Aspartate aminotransferase (AST) blood test - 妙佑医疗国际

    Girls: 8 to 50 U/L. Different labs may use slightly different numbers for AST results. Ask your healthcare team what the target AST goal is for you. Causes of ...

  10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...